fda warning letter bpc 157 compounding pharmacy considers adding a dozen peptides to its bulk drug list What's behind the push to

What's behind the push to make peptide therapies more readily available : NPR The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link FDA is moving to restrict mass marketed compounded GLP 1 products that aren't FDA approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies.

SKU: 58021347040 · From equiscorp.hu